Heska to Present at Upcoming J.P. Morgan Annual Healthcare Conference

Rhea-AI Summary

Heska Corporation (NASDAQ: HSKA) announced that CEO Kevin Wilson will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 2 p.m. ET. Registered attendees can view the presentation live, while audio-only access is available for non-registered individuals. The session will include a Q&A segment. Additionally, Heska's management will hold one-on-one meetings on the same date, with contacts provided for meeting requests. Post-event, a webcast of the presentation will be archived on Heska's website for 90 days.

LOVELAND, Colo., Jan. 5, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the 39^th Annual J.P. Morgan Healthcare Conference on Wednesday January 13, 2021 at 2 p.m. Eastern Time.

Mr. Wilson's presentation will be available to registered conference attendees in a live video format via the conference website.  A live audio-only version of the presentation and question and answer session will be available to non-registered attendees at Heska Audio-Only J.P. Morgan Conference Presentation. The webcast and presentation will be archived on Heska's website shortly after the event and a replay will be available for 90 days following the conference.

Mr. Wilson and members of Heska management will also be participating in one-on-one meetings on January 13^th. To request a meeting, please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor Relations at investorrelations@heska.com.

For more information regarding the J.P. Morgan 2020 Healthcare Conference, visit: J.P. Morgan Healthcare Conference Website.

About Heska

Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

                                                                                                           

View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-to-present-at-upcoming-jp-morgan-annual-healthcare-conference-301200833.html

SOURCE Heska Corporation

FAQ

When is Heska presenting at the J.P. Morgan Healthcare Conference?

Heska Corporation is set to present on January 13, 2021, at 2 p.m. Eastern Time.

How can I access Heska's presentation at the J.P. Morgan Conference?

Registered attendees can watch the presentation live, while audio-only access is available for non-registered participants via the conference website.

Will Heska's presentation be available after the conference?

Yes, the presentation will be archived on Heska's website for 90 days following the event.

Who is presenting for Heska at the J.P. Morgan Conference?

Kevin Wilson, CEO of Heska Corporation, will present at the conference.

What will Heska discuss during the J.P. Morgan Healthcare Conference?

The specific topics have not been detailed, but generally it includes their advanced veterinary diagnostic and specialty products.